Detalhe da pesquisa
1.
IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain.
F1000Res
; 10: 42, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33732434